APA

Kolyadina I. V., Zavalishina L. E., Ganshina I. P., Andreeva Y. Y., Frank G. A., Gordeeva O. O., Zhukova L. G., Meshcheryakov A. A., Savelov N. A., Tuzova E. A., Morozov D. A. & Poddubnaya I. V. (20191220). [Role of clustered HER2/neu amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer]. : Arkhiv patologii.

Chicago

Kolyadina I V, Zavalishina L E, Ganshina I P, Andreeva Yu Yu, Frank G A, Gordeeva O O, Zhukova L G, Meshcheryakov A A, Savelov N A, Tuzova E A, Morozov D A and Poddubnaya I V. 20191220. [Role of clustered HER2/neu amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer]. : Arkhiv patologii.

Harvard

Kolyadina I. V., Zavalishina L. E., Ganshina I. P., Andreeva Y. Y., Frank G. A., Gordeeva O. O., Zhukova L. G., Meshcheryakov A. A., Savelov N. A., Tuzova E. A., Morozov D. A. and Poddubnaya I. V. (20191220). [Role of clustered HER2/neu amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer]. : Arkhiv patologii.

MLA

Kolyadina I V, Zavalishina L E, Ganshina I P, Andreeva Yu Yu, Frank G A, Gordeeva O O, Zhukova L G, Meshcheryakov A A, Savelov N A, Tuzova E A, Morozov D A and Poddubnaya I V. [Role of clustered HER2/neu amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer]. : Arkhiv patologii. 20191220.